All cancer types, Secondary cancers
Results
Phase 1
This trial looked at a combination of olaparib and capivasertib for people who had a and there were no available. It was for people who had already had treatment.
A solid tumour is any type of cancer other than or .
The trial was supported by Cancer Research UK. It was open for people to join between 2014 and 2016. The team published the results in 2020.
Recruitment start: 31 March 2014
Recruitment end: 27 July 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Timothy Yap
AstraZeneca
Cancer Research UK
Institute of Cancer Research (ICR)
NIHR Clinical Research Network: Cancer
Royal Marsden NHS Foundation Trust
This is Cancer Research UK trial number CRUKD/14/004.
Last reviewed: 29 Sept 2024
CRUK internal database number: 11918
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
